What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Endocrinology
Internal medicine, Endocrinology, Cardiology, Insulin resistance and Insulin are his primary areas of study.
His research on Internal medicine frequently links to adjacent areas such as Diabetes mellitus.
Kazuaki Shimamoto has researched Endocrinology in several fields, including Protein kinase B, Protein kinase C and Mitochondrion.
As a member of one scientific family, Kazuaki Shimamoto mostly works in the field of Cardiology, focusing on Anesthesia and, on occasion, Infarct size, Adenosine, Cariporide, Diazoxide and Myocardial stunning.
His Insulin resistance research incorporates themes from Adipocyte, Temocapril and Case-control study.
His work on Hypertension complications as part of general Blood pressure study is frequently linked to Life style, therefore connecting diverse disciplines of science.
His most cited work include:
- The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009) (1256 citations)
- The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2014) (734 citations)
- Nucleocytoplasmic Shuttling of the NAD+-dependent Histone Deacetylase SIRT1 (541 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Internal medicine, Endocrinology, Cardiology, Blood pressure and Insulin resistance.
His Internal medicine study frequently draws connections to adjacent fields such as Diabetes mellitus.
His study brings together the fields of Kinin and Endocrinology.
His research in the fields of Heart failure, Ischemia and Ejection fraction overlaps with other disciplines such as Session.
His study in Body mass index extends to Blood pressure with its themes.
Insulin resistance is represented through his Hyperinsulinemia, Glucose clamp technique and Adiponectin research.
He most often published in these fields:
- Internal medicine (71.72%)
- Endocrinology (40.00%)
- Cardiology (27.45%)
What were the highlights of his more recent work (between 2008-2021)?
- Internal medicine (71.72%)
- Endocrinology (40.00%)
- Cardiology (27.45%)
In recent papers he was focusing on the following fields of study:
Kazuaki Shimamoto mainly focuses on Internal medicine, Endocrinology, Cardiology, Insulin resistance and Blood pressure.
His work on Valsartan is typically connected to In patient as part of general Internal medicine study, connecting several disciplines of science.
His work on Left atrial, Ejection fraction, Heart failure and Echo doppler as part of general Cardiology research is frequently linked to Quantitative assessment, bridging the gap between disciplines.
His Insulin resistance research includes elements of Dyslipidemia and Adipocyte.
His Blood pressure research incorporates elements of Stroke and Randomized controlled trial.
In his research, Olmesartan is intimately related to Pharmacology, which falls under the overarching field of Randomized controlled trial.
Between 2008 and 2021, his most popular works were:
- The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009) (1256 citations)
- The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2014) (734 citations)
- Erratum: The Japanese Society of hypertension guidelines for the management of hypertension (Hypertension Research (2009) 32 (11-23) DOI: 10.1038/hr.2008.2) (369 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Enzyme
Kazuaki Shimamoto spends much of his time researching Internal medicine, Endocrinology, Blood pressure, Cardiology and Diabetes mellitus.
His work deals with themes such as Type 2 diabetes and Fatty acid-binding protein, which intersect with Internal medicine.
His research integrates issues of Mitochondrion, Resveratrol and Mitochondrial permeability transition pore in his study of Endocrinology.
His Blood pressure research is multidisciplinary, incorporating perspectives in Randomized controlled trial, Gerontology and Pharmacology.
His work in the fields of Cardiology, such as Ejection fraction, Myocardial perfusion imaging and Coronary artery disease, overlaps with other areas such as Pulse.
His research investigates the link between Insulin resistance and topics such as Metabolic syndrome that cross with problems in Dyslipidemia, Gene polymorphism and Single-nucleotide polymorphism.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
